SIEGALL CLAY B (President and CEO) purchased 3.8% of their position (25.45K shares) of IMMUNOME INC. on the open market
Open‑market purchase worth $500.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/31/2026ACC: 0001167496-26-000003
DirectorOfficer· President and CEO
Since Oct 2023
+25.45K
Net shares
Net buyer
$500.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25.45K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.45K
Price / share
$19.67
Trade value
$500.60K
% of position
3.8%
3/27/2026
665.25K→690.70K
Total
Net shares
+25.45K
Net value
$500.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/27/2026 | P · Purchase | +25.45K | $19.67 | $500.60K | 3.8% | 665.25K | 690.70K |
| Total | +25.45K | $500.60K | ||||||
Derivative Transactions0
No derivative transactions reported